PopGenTech(美國(guó))

PopGenTech

美國(guó)PopGenTechwww.popgentech.comPopulationGeneticsTechnologies公司通過(guò)多組個(gè)體基因組的同步分析，生產(chǎn)可加速大規(guī)模群體研究的產(chǎn)品，諾貝爾獎(jiǎng)得主Dr.SydneyBrenner是本公司的聯(lián)合創(chuàng)始人。我們的專利技術(shù)取代了原先的樣本準(zhǔn)備步驟，成為下一代的DNA測(cè)序技術(shù)，它克服了禁錮發(fā)現(xiàn)的成本障礙和實(shí)踐約束。Thegoalofdevelopingpe rsonalisedmedicineisdependentonidentifyingindividualsthatarelikelytobenefitfromtreatmentwithaparticulardrug.Toachievethis,cliniciansandpharmaceuticalcompaniesneedasystemfortherapiddiscoveryofclinicalbiomarkers,suchasgeneticvariants,thatareassociatedwithdiseasepredispositionanddrugefficacyortoxicity.Clinicalbiomarkersaregeneticsignpoststhatpointtoourpotentialindividualdrugresponsivenessordiseasepredisposition.Thesearefrequentlyhiddenamongmillionsofinsignificantgenevariants.Simplisticpredictionsofanewageofpersonalisedmedicine,drivenmainlybyfastersequencingtechnology,underestimatetheresourcerequiredtoidentifynewclinicalbiomarkers.